Appointments

Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

Newsroom

  •   Email
  •   Print
  •   Share
  • Dana-Farber Blog

    • Insight Blog screenshot Insight features the latest in cancer care and research news from Dana-Farber.
    • Read the blog 
  • Dana-Farber Facts

    • cover of the Dana-Farber 2016 Facts brochureFind statistics on Dana-Farber's patient care, fundraising initiatives and achievements, and phone numbers for patients and families.
    • View Dana-Farber Facts
  • More than Courage

    • More than Courage coverLearn more about Dana-Farber and the Jimmy Fund's courageous care, innovation, and commitment to beating cancer.
    • View More than Courage
  • The Cancer Treatment Revolution

    • The Cancer Treatment Revolution book cover Dr. David Nathan, acclaimed pediatric hematologist and Dana-Farber's president from 1995 – 2000, recounts that history's triumphs and struggles in his book, The Cancer Treatment Revolution.
     

Dana-Farber Spotlight

Sign up to receive Dana-Farber Spotlight, our email newsletter.
View the current issue
Subscribe now
Unsubscribe from mailings

Media Contacts

Ellen Berlin
Director of Media Relations
617-632-4090
ellen_berlin@dfci.harvard.edu 

Molly McHale
Associate Director of Media Relations
617-632-4090
molly_mchale@dfci.harvard.edu 

 

Top News Releases

R. Coleman Lindsley, MD, PhD
Eliezer Van Allen, MD
  • November 30, 2016
  • Scientists identify unique genomic features in testicular cancer
  • Researchers led by scientists at Dana-Farber say they have identified unique genomic changes that may be integral to testicular cancer development and explain why the great majority are highly curable with chemotherapy – unlike most solid tumors.
William Sellers, MD
Geoffrey Shapiro, MD, PhD

Dana Farber In the News

Publications

    Image Alt Text
    Image Alt Text
    Image Alt Text


Content